Precipio, Inc. (PRPO) CEO Ilan Danieli on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/01/21
Precipio Signs Sales & Marketing Agreement for HemeScreen™ with Major Oncology DistributorGlobeNewsWire • 12/10/20
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/20/20
Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular PanelGlobeNewsWire • 09/22/20
Precipio Announces a Shareholder Call to Discuss its COVID-19 Progress and Future PlansGlobeNewsWire • 09/04/20
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/17/20
Precipio Announces Q2-2020 Unaudited Pathology Services Revenue Increased Approximately 50% over Q1’20GlobeNewsWire • 07/22/20
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/20/20